{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T03:40:08Z","timestamp":1748835608089,"version":"3.41.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.7759\/cureus.85208","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T03:19:16Z","timestamp":1748834356000},"source":"Crossref","is-referenced-by-count":0,"title":["Latent JAK2 V617F-Positive Myeloproliferative Neoplasm With Normal Blood Counts and Recurrent Splanchnic Vein Thrombosis in a Young Woman"],"prefix":"10.7759","author":[{"given":"Aye M","family":"Thida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Luhrs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aastha","family":"Baral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhonghua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordonna","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022, 36:1703-19. 10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine RL","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J, et al.. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005, 7:387-97. 10.1016\/j.ccr.2005.03.023","journal-title":"Cancer Cell"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter EJ","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, et al.. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005, 365:1054-61. 10.1016\/S0140-6736(05)71142-9","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James C","year":"2005","unstructured":"James C, Ugo V, Le Cou\u00e9dic JP, et al.. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005, 434:1144-8. 10.1038\/nature03546","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics R","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, et al.. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005, 352:1779-90. 10.1056\/NEJMoa051113","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-196014","article-title":"JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis","volume":"113","author":"Dentali F","year":"2009","unstructured":"Dentali F, Squizzato A, Brivio L, et al.. JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood. 2009, 113:5617-23. 10.1182\/blood-2008-12-196014","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26896","article-title":"Myeloproliferative neoplasms and splanchnic vein thrombosis: contemporary diagnostic and therapeutic strategies","volume":"98","author":"Kiladjian JJ","year":"2023","unstructured":"Kiladjian JJ, Cassinat B. Myeloproliferative neoplasms and splanchnic vein thrombosis: contemporary diagnostic and therapeutic strategies. Am J Hematol. 2023, 98:794-800. 10.1002\/ajh.26896","journal-title":"Am J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi A","year":"2008","unstructured":"Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008, 22:14-22. 10.1038\/sj.leu.2404955","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017697","article-title":"JAK2 V617F allele burden in polycythemia vera: burden of proof","volume":"141","author":"Moliterno AR","year":"2023","unstructured":"Moliterno AR, Kaizer H, Reeves BN. JAK2 V617F allele burden in polycythemia vera: burden of proof. Blood. 2023, 141:1934-42. 10.1182\/blood.2022017697","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma DP","year":"2015","unstructured":"Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, Ebert BL. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015, 126:9-16. 10.1182\/blood-2015-03-631747","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010422","article-title":"JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study","volume":"7","author":"Kristiansen MH","year":"2023","unstructured":"Kristiansen MH, Kj\u00e6r L, Skov V, et al.. JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study. Blood Adv. 2023, 7:5825-34. 10.1182\/bloodadvances.2023010422","journal-title":"Blood Adv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal S","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, et al.. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014, 371:2488-98. 10.1056\/NEJMoa1408617","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022260","article-title":"Jak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk","volume":"143","author":"Liu W","year":"2024","unstructured":"Liu W, Pircher J, Schuermans A, et al.. Jak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk. Blood. 2024, 143:1539-50. 10.1182\/blood.2023022260","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/374288-latent-jak2-v617f-positive-myeloproliferative-neoplasm-with-normal-blood-counts-and-recurrent-splanchnic-vein-thrombosis-in-a-young-woman","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T03:19:17Z","timestamp":1748834357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/374288-latent-jak2-v617f-positive-myeloproliferative-neoplasm-with-normal-blood-counts-and-recurrent-splanchnic-vein-thrombosis-in-a-young-woman"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.85208","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}